Approved Hospital Formulary
Pharmacy - Home (sharepoint.com) Contact Pharmacy
Do Not Tube List
Webpage Links
QR Code Add Formweb to your mobile device
Android iOS
Approved Hospital Formulary
Pharmacy - Home (sharepoint.com) Contact Pharmacy
Search results for:

bupivacaine liposome

bupivacaine liposome
Brand names: Exparel
Form Strength
SUSPENSION, INJECTABLE 1.3% (13.3 mg/mL)
VIEW MORE Local Anesthetics
CLASS
720000
Additional Information:

In April 2022, the P&T Committee voted to remove liposomal bupivacaine (Exparel) from formulary, with a target implementation of August 1, 2022.

See the SBAR for more details. 

Last updated: Jun. 14, 2022






This site is intended for the staff of Legacy Health.
While others may view accessible pages, Legacy Health makes no warranty, express or implied,
as to the use of this information outside of Legacy Health.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved